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AIM: To assess the utility of a volumetric low-dose computed tomography (CT) thorax
(LDCTT) protocol at a dose equivalent to a posteroanterior (PA) and lateral chest radiograph for
surveillance of cystic fibrosis (CF) patients.
MATERIALS AND METHODS: A prospective study was undertaken of 19 adult patients with
CF that proceeded to LDCTT at 12 and 24 months following initiation of ivacaftor. A previously
validated seven-section, low-dose axial CT protocol was used for the 12-month study. A
volumetric LDCTT protocol was developed for the 24-month study and reconstructed with
hybrid iterative reconstruction (LD-ASIR) and pure iterative reconstruction (model-based IR
[LD-MBIR]). Radiation dose was recorded for each scan. Image quality was assessed quanti-
tatively and qualitatively, and disease severity was assessed using a modified Bhalla score.
Statistical analysis was performed and p-values of <0.05 were considered statistically
significant.
RESULTS: Volumetric LD-MBIR studies were acquired at a lower radiation dose than the
seven-section studies (0.08  0.01 versus 0.10  0.02 mSv; p¼0.02). LD-MBIR and seven-
section ASIR images had significantly lower levels of image noise compared with LD-ASIR
images (p<0.0001). Diagnostic acceptability scores and depiction of bronchovascular struc-
tures were found to be acceptable for axial and coronal LD-MBIR images. LD-MBIR images were
superior to LD-ASIR images for all qualitative parameters assessed (p<0.0001). No significant
change was observed in mean Bhalla score between 1-year and 2-year studies (p¼0.84).
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CONCLUSIONS: The use of a volumetric LDCTT protocol (reconstructed with pure IR) enabled
acquisition of diagnostic quality CT images, which were considered extremely useful for sur-
veillance of CF patients, at a dose equivalent to a PA and lateral chest radiograph.
 2021 The Authors. Published by Elsevier Ltd on behalf of The Royal College of Radiologists.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/
4.0/).
Introduction
Pulmonary disease is the primary cause of morbidity and
mortality in patients with cystic fibrosis (CF).1 Early detec-
tion of the onset of lung disease and complications is
essential to facilitate expedient treatment adaptation with
the ultimate aim of limiting disease progression.2 The cur-
rent annual rate of lung function decline (FEV1) among all
patients with CF is approximately 0.7%, making it difficult to
detect subtle changes with standard monitoring methods,
such as chest radiography and pulmonary function tests
(PFTs).3 Several studies have demonstrated computed to-
mography (CT) to be more sensitive than chest radiography
and PFTs for the detection and surveillance of lung dis-
ease,4,5 potentially making it the most appropriate tech-
nique for monitoring pulmonary disease in the current CF
population.
The major limitation to routine adoption of CT for
monitoring CF lung disease is the substantial radiation
exposure associated with conventional chest CT compared
with plain radiography (3.5 versus 0.02 mSv).
Several dose optimisation strategies may be employed
when performing chest CT in patients with CF; the use of
low-dose protocols may include automated exposure con-
trol, and automated patient centring techniques.6 At Cork
Cystic Fibrosis Centre, Cork University Hospital, a speci-
alised CF centre, a previously published seven-section low-
dose protocol is used, consisting of a limited number of
thin CT sections to impart a mean effective dose of
0.14mSv, equivalent to the dose of a posteroanterior (PA)
and lateral chest radiograph.7 The unit has used this pro-
tocol on a routine basis to monitor pulmonary disease in CF
patients in a study assessing the safety, efficacy, and
tolerability of a range of CF transmembrane conductance
regulator (CFTR) drugs including ivacaftor (Kalydeco).8
Ivacaftor has been shown to produce significant increases
in forced expiratory volume in 1 second (FEV1) (>10% ab-
solute) and body mass index (BMI), as well as reductions in
sweat chloride levels, patient-reported respiratory symp-
toms, and pulmonary exacerbation rate in patients with
the G551D-CFTR mutation.9e11 The prevalence of this Class
III gating mutation, known as the Celtic mutation12 at Cork
Cystic Fibrosis Centre is the highest in the world at 23%,8
compared with 4% in the United States,13 making it
uniquely placed to provide single-centre insight into CFTR
potentiation. CFTR mutation frequencies are highly variable
and demonstrate regional differences in prevalence.14,15
This heterogeneity is thought to be explained by the
ethnic or geographic origin of the parents and grandpar-
ents of the affected child.14
The efficacy of many dose reduction strategies in CT was
often limited by the restraints of traditional filtered back
projection (FBP) reconstruction algorithms installed on
most CT systems. Iterative reconstruction (IR) algorithms,
which incorporate statistical information of the CT system,
including photon statistics and electronic acquisition noise,
have been the focus of much dose optimisation research in
recent years. Although available on early CT scanners, IR
was not clinically useful as the necessary computing power
was not widely available. With modern advances in com-
puter technology, IR has now become a viable option to
achieve significant dose reductions. Hybrid IR algorithms,
such as adaptive statistical IR (ASIR - GE Healthcare, Mil-
waukee, WI, USA) are the most studied methods to date in
chest CT, facilitating dose reductions of the order of 57%
while preserving image quality.16,17 In recent years, a more
computationally intense pure IR algorithm, which includes
model-based IR (MBIR); Veo (GE Healthcare, GE Medical
Systems), that uses a more complex system of prediction
models has become commercially available. As each
manufacturer has their own vendor-specific IR algorithms,
which are now widely available, the implementation of
low-dose CT protocols should be achievable in all centres.18
To date, there is a paucity of studies assessing the use of
pure IR in chest CT.19
The purpose of this prospective feasibility study was to
assess the feasibility of replacing a standard chest radio-
graph with a similar dose volumetric low-dose protocol CT
thorax (LDCTT), reconstructed with pure IR, for the sur-
veillance of pulmonary disease in patients with CF.
Materials and methods
Study population
Institutional review board approval was granted for this
study. This study forms part of a prospective study con-
ducted at Cork Cystic Fibrosis Centre, a designated tertiary
CF centre, assessing the impact of the CF transmembrane
conductance regulator, ivacaftor on the CF lung.8 As part of
this study, between March 2014 and January 2016, 19 (nine
male (47%), 10 female) clinically stable, ivacaftor-naive
adult patients with CF and at least one copy of the
G551D allele gave written informed consent to undergo a
low-dose CT thorax prior to ivacaftor treatment followed
by radiological follow-up with low-dose CT thorax at 12
and 24 months. Overall, mean age at the 12 month CT was
29.5  10.5 years (males: 25.6  7.4 and females:
33.9  12.1 years; p¼0.08).
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CT technique and image reconstruction
All studies were acquired using a 64-section multi-
detector CT system (Discovery CT 750 HD; GE Healthcare,
GEMedical Systems) without intravenous contrast material.
Seven-section low-dose protocol
A previously validated, modified seven-section, low-dose
axial CT protocol was used for the pre-treatment and first
12-month studies.7 Single anteroposterior and mediolateral
localiser radiographs were used to identify five levels at
which images were acquired (Fig 1). Images were obtained
at end-inspiration through the apices, aortopulmonary
window, carina, and at widest cardiac and thoracic di-
ameters (Fig 2aee). A further two images were obtained
with the patient in full expiration at the level of the aorto-
pulmonary window and widest cardiac diameter (Fig 2f).
The following parameters were used: 120 kV tube voltage,
0.4 seconds gantry rotation time, 32 cm field of view (FOV),
and z-axis automatic tube current modulation with mini-
mum and maximum tube current thresholds of 10 and 100
mAwith noise index of 29 HU. Images were acquired at each
level at section thickness of 0.625 mm and reconstructed to
a section thickness of 3 mm, employing hybrid IR of 40%
ASIR and 60% filtered back projection, labelled seven-
section ASIR.
Volumetric low-dose protocol
A novel low-dose volumetric protocol was designed for
24-month surveillance CT. Preliminary anthropomorphic
torso phantom (CT Torso Phantom CTU41, Kyoto Kagaku,
Fushimi-ku, Kyoto, Japan) and technical phantom (Catphan
600, The Phantom Laboratory, Greenwich, NY, USA) studies
were conducted to determine the optimal protocol settings.
Technical parameters were altered to assess radiation dose
and diagnostic quality with the following parameters indi-
cating that studies could potentially be acquired at a dose of
approximately 0.08mSv: 80 kV tube voltage, 20mA tube
current, 0.4 seconds gantry rotation time, 1.375 pitch factor,
and FOV of 32 cm. To ensure radiation exposure remained
low for all patients, a fixed tube current technique was
employed. Scanning was performed at end-inspiration from
lung apices to bases, including costophrenic recesses. In the
interests of minimising radiation exposure, no additional
expiratory phase imaging was performed. Images were ac-
quired at section thickness of 0.625mm and reconstructed
at final section thickness of 3 mm with pure IR (MBIR) in
axial, coronal, and sagittal planes (labelled LD-MBIR; Fig 3).
Images were also reconstructed with hybrid IR (40% ASIR
and 60% filtered back projection), labelled LD-ASIR. Images
were further reconstructed at the same five levels as seven-
section ASIR inspiratory phase scans to facilitate a direct,
blinded comparison between both low-dose techniques.
Dose measurements
Doseelength product (DLP) and volume CT dose index
(CTDIvol) values were recorded from each CT dose report.
Calibration of CT unit was performed once per week in
accordance with manufacturer’s instructions and following
the departmental quality-assurance protocol. The Imaging
Performance and Assessment in CT patient dosimetry
calculator (ImPACT version 0.99x, London, UK) was used to
calculate the effective dose (ED). The radiation exposure
resultant from the CT topograms was excluded from anal-
ysis, following methodology of previous published studies,
and justified by negligible radiation exposures associated
with CT topograms.
Quantitative analysis
Objective image quality analysis was performed inde-
pendently on a dedicated workstation (Advantage Work-
station VolumeShare 2, Version 4.4, GE Medical Systems) by
two operators with 6 and 7 years of radiology experience,
respectively. The operators were blinded to imaging pro-
tocol and the order of the datasets was randomised.
Attenuation values were measured in Hounsfield units at
three levels: the aortic arch, the carina, and maximum
cardiac diameter. Measurements were recorded by placing
circular regions of interest (ROIs) of equal size (10 mm
diameter) in the descending aorta and paraspinal muscles
of posterior chest wall at each level. The ROIs were placed in
as homogeneous an area as possible, taking care to avoid fat
planes and blood vessels. The standard deviation of the
attenuation in ROI served as an objective measure of image
noise. The SNR of each ROI was calculated by dividing the
mean attenuation by its standard deviation. Measurements
were taken three times by each operator to minimise error.
The mean of both operators’ measurements was used for
analysis.
Qualitative analysis
The 24-month LD-MBIR images were compared with the
same data reconstructed using ASIR (LD-ASIR). Digital im-
ages were reviewed on a PACS (Impax 6.5.3; Agfa Health-
care, Morstel, Belgium) on a monitor with resolution of 3
Figure 1 Anteroposterior scanned projection radiograph used to
identify five levels at which images were acquired for the seven-
section low-dose protocol. Images were obtained at the level of the
lung apices, aortopulmonary window, carina, and at the widest car-
diac and thoracic diameters.
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megapixels. Image noise, diagnostic acceptability, depiction
of bronchovascular structures within 2 cm of the pleural
margin, and presence of streak artefact were assessed in
consensus by two radiologists, with 13- and 22-years radi-
ology experience, respectively, at the five anatomical levels
for all datasets. The subjective image quality parameters
and grading system were selected and assessed as in prior
studies.7
Quantification of lung disease
Disease severity was scored independently by the same
two radiologists (who had significant prior experience of
assessing severity of CF) using Bhalla system.20 To mini-
mise the effects of recall bias, all datasets were anony-
mised and reviewed in a random order. In addition, a 6-
week delay was instituted between review of the 12
month seven-section ASIR studies and the 24-month LD-
MBIR studies. Images were reviewed on lung window
settings (1,500 HU window width, e500 HU window level)
on a PACS system using axial reformations for seven-
section ASIR studies and a combination of axial and coro-
nal reformations for LD-MBIR studies.
The presence and severity of ninemorphological changes
were evaluated including: severity of bronchiectasis; peri-
bronchial thickening; extent of bronchiectasis (number of
bronchopulmonary segments); extent of mucus plugging
(number of lung segments); abscesses or sacculations
(number of lung segments); generations of the bronchial
divisions involved; number of bullae; and collapse/consol-
idation following Bhalla system.20 Assessment for air-
trapping forms part of the assessment using the Bhalla
scoring system, but this could not be assessed on the
volumetric low-dose protocol (LDCT) as expiration scans
were not performed. Therefore, a modified Bhalla score,
excluding assessment for air trapping, was used for the 12
and 24-month CT examinations.
Statistical analysis
Data were exported from Microsoft Office Excel 2010
(Microsoft Corporation, Redmond, WA, USA) into GraphPad
Prism version 7.1 (GraphPad Software Incorporated, San
Diego, CA, USA) and Statistical Package for the Social Sci-
ences (SPSS) version 22 (IBM, Chicago, IL, USA) for further
analysis. Data are described as mean and standard devia-
tion for parametric distributions or as median and range
for non-parametric distributions. ManneWhitney test was
used to compare non-parametric distributions of two
groups of continuous variables. Two-way analysis of vari-
ance and Tukey’s multiple comparisons test were used to
compare quantitative measures of noise and SNR.
Figure 2 Low-dose axial CT images acquired in a 21-year-old man with CF at 12-months of treatment with ivacaftor using the seven-section
ASIR protocol (effective dose 0.1 mSv). Images were obtained at the level of the lung apices (a), aortopulmonary window (b), carina (c), and
at the widest cardiac (d) and thoracic (e) diameters. Expiration phase images were obtained at the level of the aortopulmonary window (not
shown) and at the widest cardiac diameter (f).
Figure 3 Representative coronal CT image acquired in a 23-year-old
man with CF at 24 months of treatment with ivacaftor using the
volumetric low-dose pure IR protocol (effective dose 0.08 mSv).
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Friedman’s test was used to compare qualitative measures
between datasets. Inter-rater reliability of disease quanti-
fication scores was assessed with intraclass correlations.
Normally distributed repeated parametric quantitative
indices were compared using paired t-tests. Pearson’s
correlations were used to assess the strength of association
between normally distributed continuous variables. p-
Values <0.05 were considered statistically significant.
Results
Radiation exposure
The 24-month volumetric LD-MBIR protocol was per-
formed with a mean DLP of 5.04  0.52 mGy$cm corre-
sponding to a mean ED of 0.08  0.01 mSv. The 12-month
seven-section ASIR protocol was performed with a mean
DLP of 5.89  1.24 mGy$cm with a mean ED of 0.10  0.02
mSv. LD-MBIR studies were acquired at a statistically
significantly lower radiation dose than the seven-section
ASIR studies (Table 1). The mean CTDIvol of the seven-
section ASIR studies was significantly higher than the LD-
MBIR studies as a much smaller volume of tissue received
a similar radiation dose. Effective doses were reduced by
98.5% and 98.1% compared with conventional dose volu-
metric CT thorax in an adult patient (5.4 mSv) for the LD-
MBIR and seven-section ASIR protocols, respectively.
Quantitative analysis
Quantitative measures of image noise at three levels
from each protocol are shown in Fig 4a. Both axial and
coronal LD-MBIR images were significantly superior to LD-
ASIR images at all levels (mean noise: 23.03  6.4 versus
72.53  11.58 HU (p<0.0001) and 19.2  5.7 versus
72.53  11.58 HU (p<0.0001), respectively). The greatest
mean noise difference was observed between coronal
LD-MBIR and LD-ASIR images, with the greatest difference
at the level of maximum cardiac diameter (55.8 HU).
All other comparisons at all levels were non-significant
(p¼0.08e0.94). Seven-section ASIR images had signifi-
cantly lower levels of image noise at all levels compared
with LD-ASIR images (22.15  8.9 versus 72.53  11.58 HU,
p<0.0001).
Mean SNR was also compared between each protocol at
each level (Fig 4b). Both axial and coronal LD-MBIR images
had significantly higher SNRs than LD-ASIR images at all
levels (p<0.001 for all comparisons). Seven-section ASIR
images also had significantly higher SNRs than LD-ASIR
images at all levels (p<0.0001).
Coronal LD-MBIR images were found to have signifi-
cantly higher SNRs than axial LD-MBIR images at the level
of the maximum cardiac diameter (p¼0.0002). Axial and
coronal LD-MBIR images also had significantly higher SNRs
than seven-section ASIR images at the level of the
maximum cardiac diameter (p-values of 0.017 and 0.001,
respectively). All other comparisons were non-significant.
Qualitative analysis
No significant difference was found for five anatomical
levels within each dataset for each parameter assessed;
hence, the multilevel information was summated for com-
parison between protocols (Fig 5).
Axial and coronal LD-MBIR images were significantly
superior to LD-ASIR images for all qualitative parameters
assessed (p<0.0001 for all comparisons). Diagnostic
acceptability scores on lung windows and depiction of
bronchovascular structures within 2 cm of pleural margin
were found to be acceptable for axial LD-MBIR images
(median 3, range 1e4; median 3, range 1e5, respectively)
and highly acceptable for coronal LD-MBIR images (median
4, range 2e5 for both) with coronal images being signifi-
cantly superior (p<0.0001 for both comparisons). LD-ASIR
images were minimally acceptable for both parameters
(i.e., diagnostic acceptability scores on lung windows and
depiction of bronchovascular structures; median 2, range
1e3 for both; Fig 6).
Streak artefact interfering with image interpretation was
observed more often in the LD-ASIR images (median 3,
range 2e3) than the LD-MBIR images (p<0.0001). Streak
artefact was present on axial and coronal LD-MBIR images
but it did not interfere with image interpretation (median 2,
range 1e3 for both). No significant difference was observed
in streak artefact between axial and coronal reformats.
Streak artefact was greatest at the level of the lung apices
for all reconstructions.
Quantification of lung disease
Disease severity was assessed on 12-month seven-
section ASIR studies and the 24-month LD-MBIR studies.
Inter-rater variability measures were very good for total
modified Bhalla score and all nine morphological changes
for both the seven-section ASIR studies and the LD-MBIR
studies, with intraclass correlations of 0.881 (95% confi-
dence interval [CI]: 0.69 to 0.973, p<0.001) and 0.812 (95%
CI: 0.439 to 0.937, p<0.001) for total modified Bhalla score,
respectively; hence, mean reader scores were used to assess
disease severity.
No significant change was observed in mean modified
Bhalla score between 12-month and 24-month studies
(11.03  2.7 versus 10.9  3.99, p¼0.84). There was mod-
erate strength of association between modified Bhalla score
and FEV1 at 12 months (r¼0.43, p¼0.1) and 24 months
(r¼0.78, p¼0.01). Bronchiectasis was the most severe and
Table 1
Radiation dose metrics.
Dose measurement Seven-section ASIR LD-MBIR p-Value
DLP (mGy.cm) 5.89  1.24 5.04  0.52 0.01
ED (mSv) 0.10  0.02 0.08  0.01 0.02
CTDIvol (mGy) 46.9  9.78 0.017  0.01 <0.0001
Comparison of dose measurements between seven-section and LD-MBIR
protocols. Data are expressed as mean  SD.
LD, low dose; ASIR, adaptive statistical iterative reconstruction; MBIR, model
based iterative reconstruction; DLP, doseelength product; ED, effective
dose; CTDIvol, volume computed tomography dose index.
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consistent lung abnormality identified at low dose CT. All
patients had bronchiectasis and it was rated as mild, mod-
erate and severe in 22% (n¼4), 26% (n¼5), and 52% (n¼10) at
12 months, respectively, and as mild, moderate, and severe
in 47.4% (n¼9), 10.5% (n¼2), and 42.1% (n¼8) at 24 months,
respectively. Overall, mean severity of bronchiectasis was
significantly improved at the 24-month scan (Table 2).
Clinical course
Table 3 demonstrates change in mean BMI, FEV1, and
forced vital capacity (FVC) over the study period. BMI
increased significantly compared with baseline after 12
months of treatment. FEV1 and FVC increased significantly
compared with baseline at 12 and 24 months of treatment.
No significant difference was observed for any of the mea-
sures between 12 and 24 months.
Discussion
In recent years, there has been a sixfold increase in the use
of CT in CF to monitor pulmonary disease progression and
complications.21 It is estimated that patients with CF will
undergo an average of 3.2 chest CTexaminations during their
lifetime resulting in increased lifetime cumulative effective
dose compared with the general population.22 Mean age at
first CT examination in CF patients has also fallen, from 20
years for patients born before 1980 to 1.9 years for patients
born after 1997.22 Chest CT performed at such a young age
can readily detect the earliest radiological manifestations of
CF: mucus plugging. Chest CT has also been shown to be
more sensitive for the detection of early increases in severity
of lung disease and superior for the quantification of bron-
chiectasis compared with both PFTs and chest radiography.
CT can thus provide valuable information regarding the
presence and type of complications and estimation of CF
lung disease severity, which represents vital information to
inform important management decisions.
The major limitation to the use of CT to monitor pul-
monary disease in patients with CF is the cumulative radi-
ation dose incurred.21 Physicians must remain cognisant of
the risk of radiation-induced carcinogenesis, especially
given the improving life expectancy among CF patients,23,24
and the increasing use of CT to monitor pulmonary disease.
It is imperative therefore to keep radiation exposure from
chest CT as low as reasonably possible without compro-
mising diagnostic performance.
In recent years, there has been a major industry and
academic drive to develop and implement new dose-
reduction technologies in CT. Chest CT is well suited to the
development of dose-optimisation strategies with the high
inherent contrast and low radiation absorption of the
lungs.25 Many dose-reduction strategies utilised to date
have resulted in increased levels of image noise and
reduced image quality, which have a negative impact on the
ability of CT to detect and characterise pathology. Advanced
IR algorithms have been introduced in recent years that
serve to improve image quality through noise reduction and
spatial resolution improvements, thus facilitating the gen-
eration of diagnostic quality images at reduced radiation
doses. Hybrid IR techniques are applied at different blends
with FBP to reduce image noise while preserving image
quality and the familiar appearance of traditional FBP-
reconstructed images. Hybrid IR systems have been well
validated in chest CT achieving dose reductions in the order
Figure 4 Charts depicting (a) mean image noise and (b) SNR for LD-MBIR, LD-ASIR, and seven-section ASIR protocols at each of the three levels
assessed. Data are plotted as mean and standard deviation as indicated by whiskers. LD-MBIR and seven-section ASIR images had significantly
lower levels of image noise than LD-ASIR images. All other comparisons were non-significant. Max cardiac, maximum cardiac diameter; HU,
Hounsfield units.
Figure 5 Comparison of subjective image quality parameters be-
tween axial and coronal LD-MBIR and LD-ASIR datasets. Data are
plotted as median and range. DA, diagnostic acceptability; broncho-
vascular, depiction of bronchovascular structures within 2 cm of the
pleural margin.
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of 46%e80% without compromising image quality.26,27 Pure
IR algorithms, such as MBIR used in the current study, are
more computationally intense incorporating modelling of
certain parameters previously omitted from the iteration
process. These include a system model that addresses the
nonlinear, polychromatic nature of X-ray tubes by model-
ling the photons in the data set, a statistical noise model
that considers the focal spot and detector size, and a prior
model that corrects unrealistic situations in the recon-
struction process to decrease the computational time. The
incorporation of system optic information enables re-
ductions in image noise and artefacts with improvements in
spatial resolution. Pure IR has enabled even greater dose
reductions than hybrid IR, with previous studies reporting
the acquisition of diagnostic quality chest CT images at a
dose approaching that of a PA and lateral chest radiograph
(0.16  0.006 mSv).19 An even greater dose reduction was
achieved in the present study with the protocol that
enabled the acquisition of a diagnostically acceptable, full-
volume, low-dose CT thorax at a dose equivalent to a PA
and lateral chest radiograph (0.08  0.01 mSv). Perfor-
mance of hybrid IR at this dose level was suboptimal with
LD-ASIR images having significantly higher levels of image
noise and inferior qualitative scores than LD-MBIR images.
Initial efforts at Cork Cystic Fibrosis Centre to optimise
dose from chest CT in patients with CF involved the devel-
opment of a non-contiguous thin-section protocol per-
formed at a mean effective dose of 0.1  0.05 mSv in
paediatric patients.7 Although excellent correlation was
observed between disease severity scores and chest radi-
ography scores by O’Connor et al., limiting the number of
sections to reduce dose may potentially impact accuracy of
assessment of true disease severity and may result in focal
complications, such as mucus plugging, bronchiectasis,
small areas of consolidation, or lung abscess being missed
or misclassified. The current full-volume protocol enables
complete evaluation of the entire lung parenchyma, medi-
astinum and pleural space and facilitates more reliable
calculation of CT disease severity scores. In the authors’
experience, this full-volume protocol is much more suitable
for monitoring disease progression and guiding treatment
strategies. Another major advantage is the ability to
perform high-quality 3D reconstructions. Coronal re-
constructions, in particular, are extremely useful in assess-
ing disease severity and location of parenchymal and airway
complications (including subtle mucus plugging, tree-in-
bud opacities, and small foci of ground-glass opacifica-
tion) which may herald early signs of disease progression in
CF. The additional information provided by the current low-
Figure 6 Representative LD-ASIR (hybrid IR) and LD-MBIR (pure IR) axial CT images acquired in a 22-year-old woman with CF at the level of the
maximum cardiac diameter illustrating the noise-reducing capabilities of MBIR (effective dose 0.09mSv). Diagnostic acceptability and depiction
of bronchovascular structures with 2 cm of the pleural margin were considered acceptable for the LD-MBIR image (score of 3) and minimally
acceptable (score of 2) for the LD-ASIR image.
Table 2
Modified Bhalla scores.
Lung abnormality 1-year 2-years
Bhalla score 11.03  2.7 10.9  3.99
Bronchiectasis 2.3  0.82 1.9  0.97a
Peribronchial thickening 1.3  0.89 0.58  0.90a
Extent of bronchiectasis 2.7  0.58 2.7  0.68
Extent of mucus plugging 1.5  1.17 1.5  0.90
Sacculations or abscesses 0.05  0.23 0.74  0.87a
Generations of bronchial divisions 2.5  0.90 2.3  0.82
Bullae 0.26  0.65 0.11  0.32
Collapse or consolidation 0.37  0.68 0.68  0.67a
Change in qualitative scores of disease severity, Bhalla score, between the 1-
year and 2-year CT studies. Data are expressed as mean  SD.
a Statistically significant change between the studies.
Table 3
Changes in clinical parameters.
Baseline 1-year 2-years
BMI, kg/m2 21.38  3.18 22.94  3.63a 22.37  2.44
FEV1, % predicted 63.4  17.5 74.27  16.33a 72.2  17.54a
FVC, % predicted 81.13  15.16 89.87  10.7a 86.8  14.07a
Change in BMI, body mass index; FEV1, forced expiratory volume in one
second; and FVC, forced vital capacity; over the study period. Data are
expressed as mean  SD.
a Statistically significant change compared to the baseline measurement.
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dose CT protocol at a dose equivalent to chest radiography
has been appreciated by respiratory physician colleagues
and has led to LDCT (LDMBIR protocol) replacing chest
radiography in CF patients for most clinical indications.
There are several limitations to the present study. A
concurrent conventional dose CT scanwas not performed as
a reference standard; however, an additional conventional
dose study was not ethically justifiable as the aim was to
develop a low-dose protocol to replace chest radiography
for the purpose of routine pulmonary disease assessment,
and as all patients were clinically stable, no indication
existed to perform a conventional dose study. Comparison
of disease severity scores may not be entirely comparable,
as the seven-section protocol may have led to clinically
important disease being missed. In addition, expiratory
phase imaging was omitted from the LD-MBIR protocol in
the interests of reducing dose as much as was possible.
Furthermore, the present patient cohort was small, which
limits the strength of the conclusions drawn. Imaging of the
mediastinum and upper abdomen was suboptimal with
both protocols; however, assessment of the mediastinum is
of less concern in patients with CF where evaluation of
pulmonary disease is the primary intention. This is there-
fore an acceptable limitation, given the substantial reduc-
tion in radiation dose achieved.
The findings of the present study strengthen the case for
the use of low-dose CT in patients with CF with some ex-
perts suggesting that surveillance CT should be performed
biannually.28 The present low-dose protocol could also
potentially have a role in screening for non-CF bronchiec-
tasis. Low-dose CT in this setting may detect mild bron-
chiectasis and prevent patients with early bronchiectasis
and a normal chest radiograph being misdiagnosed as
having asthma.29 Thus, in the assessment of non-CF patients
presenting with suspected bronchiectasis, consideration
should be given to the replacement of chest radiograph
with low-dose chest CT reconstructed with pure IR.
In conclusion, the use of MBIR with a volumetric low-
dose protocol enabled the acquisition of diagnostic quality
chest CT images in CF patients at a dose equivalent to that of
a PA and lateral chest radiograph.
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